Evaluation of Long-term Outcomes and its Related Factors in Patients with Immune-complex Mediated Glomerulonephritis: A 20-Year Historical Cohort Study in Iran.

IF 0.7 4区 医学 Q4 UROLOGY & NEPHROLOGY Iranian journal of kidney diseases Pub Date : 2025-02-25 DOI:10.52547/ijkd.8185
Shiva Shahnazari, Mitra Mehrazma, Shadi Naderyan Fe’li, Shahrzad Ossareh
{"title":"Evaluation of Long-term Outcomes and its Related Factors in Patients with Immune-complex Mediated Glomerulonephritis: A 20-Year Historical Cohort Study in Iran.","authors":"Shiva Shahnazari, Mitra Mehrazma, Shadi Naderyan Fe’li, Shahrzad Ossareh","doi":"10.52547/ijkd.8185","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Immune-complex mediated glomerulonephritis (IC-GN) has a poor prognosis and commonly leads to kidney failure This study reports 20-year experience with the long-term outcomes of 222 Iranian IC-GN patients.</p><p><strong>Methods: </strong>This single-center historical cohort study was conducted on patients who underwent kidney biopsies from 1998 to 2018 in Hasheminejad Kidney Center (HKC). Initial demographic, clinical, laboratory, and pathology data were extracted from the glomerulonephritis registry of HKC. Follow-up data was obtained by reviewing hospital and outpatient files, as well as phone calls. The primary outcomes were end-stage kidney disease (ESKD) and death, and the secondary outcomes were complete remission, partial remission, and stable chronic kidney disease.</p><p><strong>Results: </strong>A total of 222 patients, (141 (63.5%) males, 81 (36.5%) females, mean age: 37.76 ± 15.71 years), were diagnosed with IC-GN. The most common causes were IgA nephropathy and lupus nephritis. Among all, 60.2% progressed to ESKD, 15.5% died, 13.1% achieved complete, and 18.5% achieved partial remission. The overall one-, three-, five-, and ten-years kidney survival rates were 52%, 42%, 38%, and 27%, respectively, with a significant difference between the IC-GN subtypes (P < .001). The highest kidney survival rate was found in lupus nephritis. Significant independent predictors of ESKD were the percentage of interstitial fibrosis and tubular atrophy (adjusted hazard ratio (aHR) = 1.022 [95% confidence interval (CI) = 1.012-1.033]), percentage of active crescents (aHR = 4.002 [95% CI = 2.066-7.752]), and initial serum creatinine level (aHR = 1.073 [95% CI = 1.035-1.112]) (P < .001 for all).</p><p><strong>Conclusion: </strong>There was a significant difference between the long-term survival of IC-GN types. Histopathologic features, and higher initial serum creatinine levels, were important predictors of poor outcome.</p>","PeriodicalId":14610,"journal":{"name":"Iranian journal of kidney diseases","volume":"19 1","pages":"30-40"},"PeriodicalIF":0.7000,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian journal of kidney diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.52547/ijkd.8185","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Immune-complex mediated glomerulonephritis (IC-GN) has a poor prognosis and commonly leads to kidney failure This study reports 20-year experience with the long-term outcomes of 222 Iranian IC-GN patients.

Methods: This single-center historical cohort study was conducted on patients who underwent kidney biopsies from 1998 to 2018 in Hasheminejad Kidney Center (HKC). Initial demographic, clinical, laboratory, and pathology data were extracted from the glomerulonephritis registry of HKC. Follow-up data was obtained by reviewing hospital and outpatient files, as well as phone calls. The primary outcomes were end-stage kidney disease (ESKD) and death, and the secondary outcomes were complete remission, partial remission, and stable chronic kidney disease.

Results: A total of 222 patients, (141 (63.5%) males, 81 (36.5%) females, mean age: 37.76 ± 15.71 years), were diagnosed with IC-GN. The most common causes were IgA nephropathy and lupus nephritis. Among all, 60.2% progressed to ESKD, 15.5% died, 13.1% achieved complete, and 18.5% achieved partial remission. The overall one-, three-, five-, and ten-years kidney survival rates were 52%, 42%, 38%, and 27%, respectively, with a significant difference between the IC-GN subtypes (P < .001). The highest kidney survival rate was found in lupus nephritis. Significant independent predictors of ESKD were the percentage of interstitial fibrosis and tubular atrophy (adjusted hazard ratio (aHR) = 1.022 [95% confidence interval (CI) = 1.012-1.033]), percentage of active crescents (aHR = 4.002 [95% CI = 2.066-7.752]), and initial serum creatinine level (aHR = 1.073 [95% CI = 1.035-1.112]) (P < .001 for all).

Conclusion: There was a significant difference between the long-term survival of IC-GN types. Histopathologic features, and higher initial serum creatinine levels, were important predictors of poor outcome.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
免疫复合物介导的肾小球肾炎患者的长期预后及其相关因素的评估:伊朗20年的历史队列研究
免疫复合物介导的肾小球肾炎(IC-GN)预后差,通常导致肾衰竭。这项研究报告了222名伊朗IC-GN患者20年的长期预后。方法:对1998年至2018年在哈什米内贾德肾脏中心(HKC)接受肾活检的患者进行单中心历史队列研究。最初的人口统计学、临床、实验室和病理数据是从香港肾小球肾炎登记中提取的。通过回顾医院和门诊档案以及电话获得随访数据。主要结局是终末期肾病(ESKD)和死亡,次要结局是完全缓解、部分缓解和稳定的慢性肾病。结果:222例患者确诊为IC-GN,其中男性141例(63.5%),女性81例(36.5%),平均年龄37.76±15.71岁。最常见的病因是IgA肾病和狼疮性肾炎。其中,60.2%进展为ESKD, 15.5%死亡,13.1%完全缓解,18.5%部分缓解。总体1年、3年、5年和10年肾脏存活率分别为52%、42%、38%和27%,IC-GN亚型之间存在显著差异(P < 0.001)。狼疮性肾炎的肾脏存活率最高。ESKD的重要独立预测因子为间质纤维化和小管萎缩百分比(校正风险比(aHR) = 1.022[95%可信区间(CI) = 1.012-1.033])、活动新月百分比(aHR = 4.002 [95% CI = 2.066-7.752])和初始血清肌酐水平(aHR = 1.073 [95% CI = 1.035-1.112]) (P < 0.001)。结论:IC-GN不同类型患者的长期生存率存在显著差异。组织病理学特征和较高的初始血清肌酐水平是预后不良的重要预测因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Iranian journal of kidney diseases
Iranian journal of kidney diseases UROLOGY & NEPHROLOGY-
CiteScore
2.50
自引率
0.00%
发文量
43
审稿时长
6-12 weeks
期刊介绍: The Iranian Journal of Kidney Diseases (IJKD), a peer-reviewed journal in English, is the official publication of the Iranian Society of Nephrology. The aim of the IJKD is the worldwide reflection of the knowledge produced by the scientists and clinicians in nephrology. Published quarterly, the IJKD provides a new platform for advancement of the field. The journal’s objective is to serve as a focal point for debates and exchange of knowledge and experience among researchers in a global context. Original papers, case reports, and invited reviews on all aspects of the kidney diseases, hypertension, dialysis, and transplantation will be covered by the IJKD. Research on the basic science, clinical practice, and socio-economics of renal health are all welcomed by the editors of the journal.
期刊最新文献
A Prediction Model of Early Diabetic Nephropathy Based on Conventional Ultrasound Parameters and Hematological Indices and Its Application. Association of Angiotensin Converting Enzyme Gene Deletion/Deletion Genotype with Risk of Autosomal Dominant Polycystic Kidney Disease: A Single-center Study from Iranian Azeri Turkish Population. Comparison of Serum Phosphate Levels in Critically Ill Patients with Acute Kidney Injury Undergoing Continuous Renal Replacement Therapy Using Different Dialysates. Spontaneous Tumor Lysis Syndrome as a Complication of Metastatic Breast Cancer: A Rare Case Report. The Diagnosis of Lupus Nephritis in A Patient with Autosomal Dominant Polycystic Kidney Disease: A Rare Case Report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1